Semler Scientific, Inc. (SMLR)

Semler Scientific's stock has been impacted by a class action lawsuit alleging securities fraud related to the company's alleged failure to disclose a DOJ investigation. The disclosure of the DOJ investigation led to a stock price drop, and a subsequent agreement in principle with the DOJ to settle claims caused a further decline. The company's adoption of Bitcoin as a treasury asset has also been a notable event. Strive Inc. announced plans to acquire Semler Scientific in an all-stock deal, which led to an increase in SMLR's stock price. The stock price has seen fluctuations over the past year, with a decline as of October 24, 2025.

Semler Scientific has observed seasonality in its variable-fee revenues, with the latter half of the year experiencing softer revenues compared to the first half in both 2021 and 2022.

Semler Scientific, Inc. is a healthcare technology company focused on developing, manufacturing, and marketing products and services to improve healthcare provider effectiveness and efficiency. The company operates in the Health Care sector, specifically within the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry, and is also categorized under Diagnostic Equipment and Medical Specialties. Its flagship product is QuantaFlo, a non-invasive diagnostic tool for early detection of peripheral arterial disease (PAD) and other cardiovascular diseases. The company also offers software solutions and a multi-test service platform called WellChec. Semler Scientific has adopted Bitcoin as its primary treasury reserve asset and invests in Bitcoin.

Semler Scientific, Inc. provides its technology solutions primarily in the United States. The company's headquarters are located in Campbell, California, previously Santa Clara, California.

Semler Scientific's brand reputation has been negatively affected by class action lawsuits related to alleged securities fraud and the DOJ investigation. The disclosure of the investigation and subsequent settlement agreement has likely impacted the company's transparency perception. The adoption of Bitcoin as a treasury asset could also influence its reputation.

Ownership of Semler Scientific, Inc. is distributed among institutional investors, individual investors, and company insiders. Individual investors collectively hold the largest share, followed by institutional investors and insiders. Major institutional shareholders include Morgan Stanley, Interchange Capital Partners, LLC, and Vanguard Group Inc. Key individual shareholders include Herbert J. Semler and William H. Chang. Eric Semler is the Chairman of the Board, and Douglas Murphy-Chutorian is the CEO.